BCWorldPharm Co Ltd (200780) Stock Price & News

200780:KOSDAQ

BCWorldPharm Co Ltd

₩2,825.00

-0.88%

(-25.00) 1D

Oct 26, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 200780...

Open

₩2,830

High

₩2,975

Low

₩2,820

Mkt. cap

30.13B

Avg. vol.

5.76K

Volume

2.14K

Dividend

3.22%

Quarterly dividend

₩23

Ex-dividend date

Dec 29, 2025

52-wk high

₩6,030

52-wk low

₩2,780

EPS

-₩338

Shares outstanding

10.67M

No. of employees

289

Open

₩2,830

High

₩2,975

Low

₩2,820

Mkt. cap

30.13B

Avg. vol.

5.76K

Volume

2.14K

Dividend

3.22%

Quarterly dividend

₩23

Ex-dividend date

Dec 29, 2025

52-wk high

₩6,030

52-wk low

₩2,780

EPS

-₩338

Shares outstanding

10.67M

No. of employees

289

Related stocks

033270

KOREA UNITED PHARM INC

₩16,800.00

-1.35%

019170

Shinpoong Pharmaceutical Co Ltd

High Tech Pharm Co Ltd

₩8,880.00

-2.63%

News stories

From web sources and news partners

TradingView

36 minutes ago

Robot Consulting announces receipt of Nasdaq delisting determination

Yahoo Finance

27 minutes ago

The Nasdaq Composite Just Plunged Almost 700 Points in One Day: Is a Stock Market Crash Imminent?

Bloomberg.com

18 hours ago

Zero-Day Option Traders Are Betting Against Big S&P 500 Swings

Stocktwits

6 hours ago

Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus

About BCWorldPharm Co Ltd

CEOHong Sung Han

Employees289

Founded1980

Headquarters-

SectorPharmaceutical industry

Websitebcwp.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.25B	20.28B	19.83B	20.96B
Cost of goods sold	12.14B	12.23B	11.84B	13.63B
Cost of revenue	12.14B	12.23B	11.84B	13.63B
Research and development expenses	2.42B	2.21B	2.01B	2.75B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.12B	4.77B	3.87B	4.19B
Operating expense	6.96B	7.34B	6.18B	7.18B
Total operating expenses	19.10B	19.56B	18.03B	20.81B
Operating income	147.54M	719.12M	1.81B	147.30M
Other non operating income	93.01M	654.86M	80.68M	-335.87M
EBT including unusual items	-834.62M	346.56M	939.45M	-1.23B
EBT excluding unusual items	-743.67M	372.30M	959.26M	-1.21B
Income tax expense	146.11M	415.72M	153.81M	-229.12M
Effective tax rate	-17.51%	119.96%	16.37%	18.64%
Other operating expenses	80.59M	93.16M	77.63M	76.76M
Net income	-1.11B	-983.61M	332.94M	-1.13B
Net profit margin	-5.78%	-4.85%	1.68%	-5.41%
Earnings per share	-	-	-	-
Interest and investment income	49.94M	19.53M	15.90M	12.23M
Interest expense	-994.96M	-1.10B	-995.05M	-1.06B
Net interest expenses	-945.02M	-1.08B	-979.15M	-1.04B
Depreciation and amortization charges	132.65M	137.56M	142.11M	143.11M
EBITDA	2.13B	2.76B	3.88B	2.25B
Gain or loss from assets sale	1.00K	2.61M	41.53K	6.00M

Ask anything